相关实验视频

Updated: Sep 17, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

早期和延迟的阿兹武丁给药对COVID-19死亡率的影响:一项回顾性研究

Luo Wang¹, Yaqi Wang¹, Yan Xu¹

¹Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing, 100730, China.

Scientific reports

|July 2, 2025

概括

治疗COVID-19的阿兹武丁似乎在症状出现后8天内最有效,显著降低死亡率和疾病进展. 这一发现凸显了阿兹武丁在成年患者的早期干预的重要性.

科学领域:

* 传染病传染病
* 药理学药理学药理学
* 临床医学临床医学

背景情况:

*阿兹武丁是2019年冠状病毒病 (COVID-19) 的推治疗方法.
* Azvudine的最佳时间和对患者死亡率的影响尚不清楚.
*了解治疗窗口对于最大限度地提高治疗疗效至关重要.

研究的目的:

* 为了确定阿兹武丁在COVID-19患者的最佳治疗时间窗口.
* 为了比较Azvudine在这个窗口内和之后的预后影响.
* 评估阿兹武丁对28天全因死亡率和疾病进展的影响.

主要方法:

*对421名COVID-19患者进行单一中心的回顾性研究,这些患者接受了Azvudine治疗.
* 倾向性得分匹配用于比较302名阿兹丁患者和302名未接受治疗的患者.
*多变量逻辑回归分析,对共变量进行调整,以评估结果.

主要成果:

*阿兹武丁的使用在症状出现后8天内对COVID-19患者具有显著的保护作用.
* Azvudine 治疗减少了28天全因死亡率 (OR 0.55) 和疾病进展率 (OR 0.52).
*阿兹武丁的益处在症状出现后8天内服用时更为明显.

结论:

*在症状出现后8天内服用阿兹武丁似乎可以降低成年COVID-19患者的死亡率.
* 早期启动阿兹武丁治疗与改善患者预后有关.
* 需要进一步的大型随机对照试验来验证这些发现.

关键词:

亚兹丁 (azvudine) 是一种阿兹丁 (azvudine) 的一种药物.在 COVID-19 疫情中,死亡率死亡率死亡率这就是SARS-CoV-2病毒.治疗时间窗口

更多相关视频

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells

Published on: January 18, 2019

相关概念视频

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Factors Affecting the Risk of Infection

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...